When an LP can't meet a drawdown request, what happens? What recourse does a GP have? Ed Hall from law firm Goodwin analyses the remedy and negotiation points in this extract from The LPA Anatomised.
Proskauer's Nigel van Zyl discusses investment period and fund term extensions, in this extract from The LPA Anatomised.
The new tax laws brought in a withholding tax on partnership interests held by non-US people. James McCredie of Macfarlanes explains the implications.
Proskauer's Nigel van Zyl explains the key commercial, legal and investor relationship issues GPs need to consider before amending the agreement's provisions or restructure funds.
Star Mountain Capital founder and chief executive Brett Hickey tells us why specialised secondaries have an advantage.
GPs need to show they can handle their end-of-life funds when raising a new fund.
Negotiations and arrangements for the remaining portfolio – including potential secondaries sales – can prove fiendishly complicated, writes Julia Corelli of law firm Pepper Hamilton.
In the third part of our series, Cyril Demaria, head of private markets at Wellershoff & Partners, argues the wait for returns is not as long as people think.
In the second part of our series, Cyril Demaria, head of private markets at Wellershoff & Partners, examines the evidence that secondaries perform better than funds of funds.
In the first of a three-part series, Cyril Demaria, head of private markets at Wellershoff & Partners, says that new entrants into the secondaries market often underestimate the amount of information and level of insight required to succeed.